Acne conglobata is a rare, chronic form of severe acne with large pus-filled nodules and abscesses that join into masses or plaques. Evidence supports clinical diagnosis with selective testing and careful first-line treatment, trial data remain thin, and prompt medical care is the practical next step. It often resists common acne therapies and follows a long, progressive course. Readers who suspect it should focus on recognition, triggers, and timely dermatology care rather than self-treatment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does it look like?
- Who develops it and what raises risk?
- How do clinicians diagnose and treat it?
- What are the limits and next steps?
What does it look like?
The core lesions are large inflammatory nodules, abscesses, cysts, widespread blackheads, draining channels, and irregular scars. Dermatology and Therapy describes the coalescing nodules and treatment resistance in its 2025 review. It flourishes especially on the back and trunk.
Grouped pustules favor the trunk and rarely affect the face, while blackheads are common and progression is slow without systemic complaints. The course is chronic rather than a brief breakout. Persistent draining lesions, connected tracts, and thickened plaques distinguish it from typical teenage acne.
Who develops it and what raises risk?
Those affected are typically males in the teens through the thirties. A cited 1974 U.S. estimate counted 1,319,000 men and 832,000 women ages 15-44, a ratio of 1.6 to 1.
Anabolic-androgen steroids can trigger acne conglobata even without prior acne. Lower vitamin D levels have correlated with greater acne severity in studies. Antibiotic resistance adds to treatment difficulty. That pattern helps explain why standard antibiotic courses often fail to control spreading disease.
How do clinicians diagnose and treat it?
Diagnosis is clinical, with pus culture when lesions drain. Dermatologists assess nodules, cysts, sinus tracts, scarring, distribution, and course before choosing therapy. Isotretinoin is considered first-line therapy because it shrinks sebaceous glands and reduces sebum and Cutibacterium acnes.
It must start conservatively because it can paradoxically worsen flares. Starting low, monitoring closely, and adjusting under specialist supervision matter more than speed. Readers should bring a full drug, supplement, and steroid-exposure history to the visit.
What are the limits and next steps?
Large prospective management trials are lacking. The 2025 EuroGuiDerm acne guideline states that very little trial information exists to compare treatments for severe nodular or conglobate acne, as detailed in the long guideline version.
That limit means treatment relies on clinical judgment, close follow-up, and scar prevention. It also makes early referral valuable before tracts and scarring extend. Seek urgent care for signs that may signal acne fulminans, described by StatPearls in its clinical summary:.
- sudden fever, malaise, or joint pain
- rapid ulceration of acne lesions
- abrupt worsening after isotretinoin or steroid exposure